CU6 12.1% $7.67 clarity pharmaceuticals ltd

Ann: Clarity launches $121 million equity raise, page-19

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 23,532 Posts.
    lightbulb Created with Sketch. 1482
    I get the arguments for looking after existing holders but in reality how many existing retail holders even want to buy more up here? I wouldn't be buying in the raise regardless of the quantity I was allowed to buy simply because it makes no sense to average up at a >150% premium to my cost(and plenty of people here have lower cost base than me). We all knew a raise was going to come sooner or later, we've all had ample opportunity to load up at well below the raise price and we'll get the opportunity to buy somewhere near the raise price most likely anyway

    My own view with any company I hold stock in, just do a placement and make sure the stock goes to quality holders and get on with it, don't waste a month farting around doing a rights issue/spp - saves the company money and dilution too
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.